ROCKET PHARMACEUTICALS INC (RCKT)

US77313F1066 - Common Stock

21.98  -0.12 (-0.54%)

After market: 21.98 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
259.66M221.14M167.25M134.30M76.15M
Research and Development
186.34M165.57M125.48M106.38M58.62M
Selling, General, and Administrative Expenses
73.32M55.57M41.77M27.92M17.53M
Operating Income
-259.66M-221.14M-167.25M-134.30M-76.15M
Interest Income/Expense
3.41M2.03M90.00K-4.82M-2.54M
Other Income/Expense
10.65M450.00K-1.91M-580.00K1.43M
Non Recurring Items
N/A-3.20MN/AN/AN/A
Income Before Taxes
-245.59M-221.86M-169.07M-139.70M-77.27M
Net Income
-245.59M-221.86M-169.07M-139.70M-77.27M
EBITDA
-252.56M-214.87M-161.88M-133.15M-75.72M
 
Per Share Data
EPS Diluted Total Ops
-2.92-3.26-2.67-2.52-1.58
Non GAAP EPS
-2.94-3.29-2.68-2.51-1.58
 
Statistics

All data in USD

Charts